For the Inventor, By the Inventor

Enter assignee name

Hennigsdorf, Germany

Intersect Ent Gmbh

USPTO Granted Patents = 47

CIPO Patents = 26

EPO Patents = 15

Trademarks = 17

Forward Citations = 2,609

Loading Chart...

Loading Chart...

39 inventors (with patents filed for the assignee):

Donald J Eaton (25 out of 37 patents)

Anthony J Abbate (19 out of 41 patents)

Rodney A Brenneman (18 out of 124 patents)

4. Bin Huang (13 out of 119 patents)

5. Gail M Zaler (13 out of 13 patents)

6. David C Gale (13 out of 149 patents)

7. Richard E Kaufman (10 out of 11 patents)

8. Mary Lynn Moran (10 out of 14 patents)

9. Patrick A Arensdorf (8 out of 17 patents)

10. Thomas R Tice (8 out of 49 patents)

11. David B Downie (8 out of 8 patents)

12. Danielle L Biggs (7 out of 18 patents)

13. John Joseph Stankus (7 out of 72 patents)

14. James Su (6 out of 15 patents)

15. Vijaykumar Reddy Rajasekhar (3 out of 16 patents)

47 patents: Sort by Forward Citations

1. 12403291 - Submucosal bioresorbable drug eluting platform (2025-09-02),

2. 12064577 - Drug-coated balloon (2024-08-20),

3. 11826494 - Self-expanding devices and methods therefor (2023-11-28),

4. 11672960 - Systems, devices, and method for treating a sinus condition (2023-06-13),

5. 11672959 - Expandable member systems and methods for drug delivery (2023-06-13),

6. 11654216 - Self-expanding devices and methods therefor (2023-05-23),

7. 11497835 - Self-expanding devices and methods therefor (2022-11-15),

8. 11484693 - Expandable devices and methods for treating a nasal or sinus condition (2022-11-01),

9. 11413096 - System for the reconstruction of symmetrical body parts (2022-08-16),

10. 11337661 - Medical navigation system with wirelessly connected, touch-sensitive screen (2022-05-24),

11. 11291812 - Sinus delivery of sustained release therapeutics (2022-04-05),

12. 11123091 - Device and methods for treating paranasal sinus conditions (2021-09-21),

13. 11110210 - Self-expanding devices and methods therefor (2021-09-07),

14. 10814108 - Drug-coated balloon (2020-10-27),

15. 10688289 - Systems and methods for sinus access (2020-06-23),

Intersect ENT GmbH is a biotechnology company focused on providing innovative solutions for patients with ear, nose, and throat (ENT) conditions. With a mission to improve the quality of life for patients suffering from chronic sinusitis, Intersect ENT GmbH develops and commercializes advanced products that enable minimally invasive treatments. Their flagship product, PROPEL sinus stent, helps maintain sinus openings and improve post-surgical outcomes. Intersect ENT GmbH is committed to advancing the treatment options available to ENT specialists and providing relief to patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

47 Patents

#2 in Hennigsdorf

#1,151 in Germany

#14,382 in the World

Hennigsdorf, Germany

Intersect Ent Gmbh

Forward Citations = 2,609

39 inventors:

Donald J Eaton (25 out of 37 patents)

Anthony J Abbate (19 out of 41 patents)

Rodney A Brenneman (18 out of 124 patents)

4. Bin Huang (13 out of 119 patents)

5. Gail M Zaler (13 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…